As of 2:23pm ET
| -0.10 / -0.93%|
The 7 analysts offering 12-month price forecasts for Sucampo Pharmaceuticals Inc have a median target of 15.00, with a high estimate of 27.00 and a low estimate of 13.00. The median estimate represents a +40.85% increase from the last price of 10.65.
The current consensus among 7 polled investment analysts is to Buy stock in Sucampo Pharmaceuticals Inc. This rating has held steady since March, when it was unchanged from a Move your mouse over past
months for detail
Move your mouse over a quarter or year to see how estimates have changed over time.